{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:15:42Z","timestamp":1787494542439,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The main objective of this study was to determine if family history of malignant peripheral nerve sheath tumor (MPNST) increases risk of developing an MPNST in patients with neurofibromatosis-1 (NF-1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Individuals with NF-1 registered with the Children\u2019s Tumor Foundation\u2019s Neurofibromatosis Registry were emailed an anonymous 15-minute survey with regard to personal and family history of NF-1, MPNST, ages of onset, and symptomatology. Participation was voluntary and information was self-reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The survey was sent to 4801 registrants, 878 responded. Presence of a family history of MPNST was found to be a risk factor for the development of MPNST; 19.4% of respondents confirming a family history of MPNST developed MPNST compared with 7.5% of respondents with no family history (odds ratio, 2.975; 95% confidence interval, 1.232-7.187;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.021). NF-1 patients with a positive family history developed MPNST at a younger age than those with no family history (8.3% vs. 0.5%\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.003 and 13.9% vs. 2.4%\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.003, for onset before 10 and 20, respectively). In the MPNST population with a known family history, onset prior to age 10 was significantly more prevalent (42.9% vs. 7%\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.029).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>These results suggest a positive family history of MPNST represents a risk factor for the development and early onset of MPNST in individuals with NF-1.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mph.0000000000001156","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T17:00:11Z","timestamp":1524243611000},"page":"e359-e363","source":"Crossref","is-referenced-by-count":17,"title":["Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis: Impact of Family History"],"prefix":"10.1097","volume":"40","author":[{"given":"Fatema","family":"Malbari","sequence":"first","affiliation":[{"name":"Division of Child Neurology, Texas Children\u2019s Hospital, Baylor College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menachem","family":"Spira","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"B. Knight","sequence":"additional","affiliation":[{"name":"Children\u2019s Tumor Foundation Clinical Program, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Pediatric Hematology\/Oncology and Marrow and Blood Cell Transplantation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Roth","sequence":"additional","affiliation":[{"name":"Division of Pediatrics, MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Gill","sequence":"additional","affiliation":[{"name":"Division of Pediatrics, MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Abbott","sequence":"additional","affiliation":[{"name":"Neurosurgery, Children\u2019s Hospital at Montefiore, Albert Einstein College of Medicine, Bronx"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Levy","sequence":"additional","affiliation":[{"name":"Pediatric Hematology\/Oncology and Marrow and Blood Cell Transplantation"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","article-title":"Distinctive cancer associations in patients with neurofibromatosis type 1","volume":"34","author":"Uusitalo","year":"2016","journal-title":"J Clin Oncol"},{"key":"R2-20230918","first-page":"1573","article-title":"International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis","volume":"62","author":"Ferner","year":"2002","journal-title":"Cancer Res"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s11060-013-1345-6","article-title":"Pediatric and adult malignant peripheral nerve sheath tumors: an analysis of data from the surveillance, epidemiology, and end results program","volume":"116","author":"Amirian","year":"2014","journal-title":"J Neurooncol"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrclinonc.2013.144","article-title":"Advances in the treatment of neurofibromatosis-associated tumours","volume":"10","author":"Lin","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1634\/theoncologist.2013-0328","article-title":"Malignant peripheral nerve sheath tumors","volume":"19","author":"Farid","year":"2014","journal-title":"Oncologist"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3171\/2015.12.JNS152443","article-title":"Patterns of recurrence and survival in sporadic, neurofibromatosis type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors","volume":"126","author":"Watson","year":"2017","journal-title":"J Neurosurg"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1212\/01.wnl.0000168830.79997.13","article-title":"Association between benign and malignant peripheral nerve sheath tumors in NF1","volume":"65","author":"Tucker","year":"2005","journal-title":"Neurology"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans","year":"2002","journal-title":"J Med Genet"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/jmedgenet-2012-100978","article-title":"Neurofibromatosis type 1: from genotype to phenotype","volume":"49","author":"Pasmant","year":"2012","journal-title":"J Med Genet"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/gepi.1129","article-title":"Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1)","volume":"23","author":"Szudek","year":"2002","journal-title":"Genet Epidemiol"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"e0178639","DOI":"10.1371\/journal.pone.0178639","article-title":"Characterization and utilization of an international neurofibromatosis web-based, patient-entered registry: an observational study","volume":"12","author":"Seidlin","year":"2017","journal-title":"PLoS One"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00432-008-0523-y","article-title":"Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI","volume":"135","author":"Matsumine","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/annonc\/mdm450","article-title":"[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study","volume":"19","author":"Ferner","year":"2008","journal-title":"Ann Oncol"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11060-007-9501-5","article-title":"The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progression","volume":"87","author":"Fisher","year":"2008","journal-title":"J Neurooncol"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00259-008-1038-0","article-title":"[18F]-FDG PET\/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1","volume":"36","author":"Warbey","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1215\/15228517-2008-011","article-title":"Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1","volume":"10","author":"Mautner","year":"2008","journal-title":"Neuro Oncol"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/cncr.24755","article-title":"Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign","volume":"116","author":"Benz","year":"2010","journal-title":"Cancer"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1470-2045(11)70119-X","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study","volume":"12","author":"Villani","year":"2011","journal-title":"Lancet Oncol"},{"key":"R19-20230918","first-page":"1159","article-title":"Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer","volume":"109","author":"Giardiello","year":"2014","journal-title":"J Gastroenterol"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/gut.2007.136127","article-title":"Guidelines for the clinical management of familial adenomatous polyposis (FAP)","volume":"57","author":"Vasen","year":"2008","journal-title":"Gut"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/GIM.0b013e318216cc6d","article-title":"Multiple endocrine neoplasia type 2: an overview","volume":"13","author":"Moline","year":"2011","journal-title":"Genet Med"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.14694\/EdBook_AM.2014.34.e44","article-title":"Predisposition to pediatric and hematologic cancers: a moving target","volume":"34","author":"Malkin","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/neuonc\/nou140","article-title":"Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis","volume":"17","author":"Danielsen","year":"2015","journal-title":"Neuro Oncol"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"35753","DOI":"10.18632\/oncotarget.7099","article-title":"Dual mTORC1\/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells","volume":"7","author":"Varin","year":"2016","journal-title":"Oncotarget"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201808000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:17:49Z","timestamp":1694996269000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201808000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001156","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}